Jarkas Nachwa, McConathy Jonathan, Votaw John R, Voll Ronald J, Malveaux Eugene, Camp Vernon M, Williams Larry, Goodman Robin R, Kilts Clinton D, Goodman Mark M
Department of Radiology, Division of Radiological Sciences, Emory University, Atlanta, GA 30322, USA.
Nucl Med Biol. 2005 Jan;32(1):75-86. doi: 10.1016/j.nucmedbio.2004.07.001.
[11C]N,N-Dimethyl-2-(2'-amino-4'-ethylphenylthio)benzylamine ([11C]EADAM) was synthesized in the development of a serotonin transporter (SERT) imaging ligand for positron emission tomography (PET). The methods of ligand synthesis, results of in vitro characterization, 11C labeling and in vivo micro-PET imaging studies of [11C]EADAM in cynomolgus monkey brain are described. 11C was introduced into N,N-dimethyl-2-(2'-amino-4'-ethylphenylthio)benzylamine (5) by alkylation of N-methyl-2-(2'-amino-4'-ethylphenylthio)benzylamine (10) in 32% radiochemical yield (end of bombardment [EOB], decay-corrected from [11C]methyl iodide). Competition binding assays in cells stably expressing the transfected human dopamine transporter (DAT), SERT and norepinephrine transporter (NET) labeled with [3H]WIN 35428 or [(125)I]RTI-55, [3H]citalopram and [3H]nisoxetine, respectively, indicated the following order of SERT affinity: ADAM>EADAM>>fluvoxamine. The affinity of EADAM for DAT and NET was 500- and >1000-fold lower, respectively, than for SERT. Micro-PET brain imaging studies in a cynomolgus monkey demonstrated high [11C]EADAM uptake in the striatum, thalamus and brainstem. [11C]EADAM uptake in these brain regions peaked in less than 60 min following administration of [11C]EADAM. The tissue-to-cerebellum ratios of the striatum, thalamus and brainstem were 1.67, 1.71 and 1.63, respectively, at 120 min postinjection of [11C]EADAM. Analysis of monkey arterial plasma samples using high-pressure liquid chromatography determined there was no detectable formation of lipophilic radiolabeled metabolites capable of entering the brain. In a displacement experiment with citalopram in a cynomolgus monkey, radioactivity in the striatum, thalamus and brainstem was displaced 20-60 min after administration of citalopram. In a blocking experiment with citalopram in a cynomolgus monkey, radioactivity in the striatum, thalamus and brainstem was significantly reduced. These results support the candidacy of [11C]EADAM as a radioligand for visualizing brain SERT using PET.
[11C]N,N-二甲基-2-(2'-氨基-4'-乙基苯硫基)苄胺([11C]EADAM)是在开发用于正电子发射断层扫描(PET)的5-羟色胺转运体(SERT)成像配体过程中合成的。本文描述了[11C]EADAM在食蟹猴脑中的配体合成方法、体外表征结果、11C标记以及体内微型PET成像研究。通过用[11C]甲基碘对N-甲基-2-(2'-氨基-4'-乙基苯硫基)苄胺(10)进行烷基化反应,将11C引入到N,N-二甲基-2-(2'-氨基-4'-乙基苯硫基)苄胺(5)中,放射化学产率为32%(轰击结束[EOB],从[11C]甲基碘衰变校正)。在分别用[3H]WIN 35428或[(125)I]RTI-55、[3H]西酞普兰和[3H]尼索西汀标记的稳定表达转染人多巴胺转运体(DAT)、SERT和去甲肾上腺素转运体(NET)的细胞中进行的竞争结合试验表明,SERT亲和力顺序如下:ADAM>EADAM>>氟伏沙明。EADAM对DAT和NET的亲和力分别比对SERT低500倍和>1000倍。对食蟹猴进行的微型PET脑成像研究表明,[11C]EADAM在纹状体、丘脑和脑干中摄取量很高。在给予[11C]EADAM后不到60分钟,这些脑区的[11C]EADAM摄取量达到峰值。在注射[11C]EADAM后120分钟时,纹状体、丘脑和脑干与小脑的组织比分别为1.67、1.71和1.63。使用高压液相色谱法分析猴动脉血浆样本,结果表明未检测到能够进入脑内的亲脂性放射性标记代谢物的形成。在食蟹猴中用西酞普兰进行的置换实验中,给予西酞普兰后20 - 60分钟,纹状体、丘脑和脑干中的放射性被置换。在食蟹猴中用西酞普兰进行的阻断实验中,纹状体、丘脑和脑干中的放射性显著降低。这些结果支持[11C]EADAM作为一种使用PET可视化脑SERT的放射性配体的候选资格。